Alys Pharmaceuticals raised $100 million seed with Medicxi
04 February 2024
04 February 2024
Total investments received (USD): 100m
Round value (USD): 100m
Round investors:
Medicxi
Company: Alys Pharmaceuticals
Related deals
Asceneuron raised $100m in Series C funding led by Novo Nordisk
Investments
04 July 2024
T3 Pharmaceuticals was acquired by Boehringer Ingelheim for $508m
Secondary
22 November 2023
Belgium
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain